Cerner Analyst Resume After the Oracle Health Rebrand
The Oracle Health rebrand did not erase Cerner Millennium from job postings -- it doubled the keyword problem. Hiring managers at health systems still search Cerner and PowerChart internally, while some procurement teams and newer postings now say Oracle Health and Oracle Cerner. A build analyst resume that drops either vocabulary loses half its matches before a human reads a word.
Should you say Cerner or Oracle Health on your resume?
Use both, deliberately. The dual-listing convention is the safest approach in 2026: write Oracle Health (Cerner Millennium) in your Skills section header and use whichever term appears in the specific job posting for the first mention in your summary. ATS systems at large health systems often have legacy keyword libraries that still parse Cerner separately from Oracle, so dropping the legacy name is a genuine match risk.
Here is a Skills-section format that captures both:
EHR Platforms: Oracle Health (Cerner Millennium) -- PowerChart | FirstNet | PharmNet |
Order Management | Results Review | Dynamic Documentation
Build Tools: Discern Rules Engine | PowerChart Customization | Order Sets |
Preference Lists | CareAware iBus | Discern Explorer
Notice that module-level names (PowerChart, FirstNet, PharmNet) are listed under the parent even though they carry the Cerner-era brand. This is intentional -- recruiter searches routinely query module names independently of the parent platform name.
How do you write build bullets that survive both keyword environments?
The structure is: action verb + module/tool named explicitly + scope of change + measurable outcome or stakeholder impact. The Oracle Health / Cerner duality shows up in the module name -- keep both present:
Before (generic, no platform name):
Built and tested order sets for the emergency department.
After (dual-brand, outcome-anchored):
Designed and validated 14 ED order sets in Oracle Health (Cerner) Order Management, reducing pharmacy clarification calls by approximately 30% over 90 days post-go-live; confirmed with ED charge pharmacist.